Oral immunotherapy with transgenic rice seed containing destructed Japanese cedar pollen allergens, Cry j 1 and Cry j 2, against Japanese cedar pollinosis
- 16 October 2012
- journal article
- Published by Wiley in Plant Biotechnology Journal
- Vol. 11 (1), 66-76
- https://doi.org/10.1111/pbi.12007
Abstract
Transgenic rice accumulating the modified major Japanese cedar pollen allergens, Cryptomeria japonica 1 (Cry j 1) and Cryptomeria japonica 2 (Cry j 2), which were deconstructed by fragmentation and shuffling, respectively, in the edible part of the seed was generated by transformation of a good-tasting rice variety, 'Koshihikari'. These modified cedar pollen antigens were deposited in ER-derived protein bodies (PB-I), which are suitable for delivery to the mucosal immune system in gut-associated lymphoid tissue when orally administered because antigens bioencapsulated in PB-I are resistant against hydrolysis by intestinal enzymes and harsh environments. Mice fed transgenic seeds daily for three weeks and then challenged with crude cedar pollen allergen showed marked suppression of allergen-specific CD4(+) T-cell proliferation, IgE and IgG levels compared with mice fed nontransgenic rice seeds. As clinical symptoms of pollinosis, sneezing frequency and infiltration of inflammatory cells such as eosinophils and neutrophils were also significantly reduced in the nasal tissue. These results imply that oral administration of transgenic rice seeds containing the structurally disrupted Cry j 1 and Cry j 2 antigens, serving as universal antigens, is a promising approach for specific immunoprophylaxis against Japanese cedar pollinosis.Keywords
This publication has 54 references indexed in Scilit:
- Recombinant allergens for specific immunotherapyJournal of Allergy and Clinical Immunology, 2011
- The Induced Regulatory T Cell Level, Defined as the Proportion of IL-10+Foxp3+ Cells among CD25+CD4+ Leukocytes, Is a Potential Therapeutic Biomarker for Sublingual Immunotherapy: A Preliminary ReportInternational Archives of Allergy and Immunology, 2010
- Effect of Sublingual Immunotherapy on Antigen-Induced Bronchial and Nasal Inflammation in MiceInternational Archives of Allergy and Immunology, 2010
- Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B miceProceedings of the National Academy of Sciences of the United States of America, 2010
- Developments in allergen‐specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen‐specific immunoglobulin E and T cell reactivityClinical and Experimental Allergy, 2010
- Sublingual Immunotherapy for Japanese Cedar PollinosisAllergology International, 2009
- Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivativesClinical and Experimental Allergy, 2008
- Effect of Cry-consensus Peptide, a Novel Recombinant Peptide for Immunotherapy of Japanese Cedar Pollinosis, on an Experimental Allergic Rhinitis Model in B10.S MiceAllergology International, 2007
- High accumulation of bioactive peptide in transgenic rice seeds by expression of introduced multiple genesPlant Biotechnology Journal, 2006
- Mechanisms of immunotherapyJournal of Allergy and Clinical Immunology, 2004